pulque
08-06-2004, 17:41
http://www.granma.cu/ingles/2004/julio/vier16/30cancer.html
First Cuban-U.S. cooperation agreement for production of anti-cancer vaccines
• President Fidel Castro attends the document’s signing
BY REYNOLD RASSĂŤ -Granma daily staff writer-
ON July 15, and for the first time in 40 years, a cooperation agreement was signed by Cuban and U.S. companies for the transfer of biotechnological technology directed at developing vaccines against cancer. The agreement was signed between the CancerVax Corporation and the Center for Molecular Immunology at the International Conference Center in Havana.
------snip-------
For technical reasons, a complex negotiations process is already underway involving three different cancer vaccines, all under the protection of six patents from the Center for Molecular Immunology and the Genetic Engineering and Biotechnology Center, with different manufacturing processes, Lage noted.
“This negotiation has additional complications, and anyone could recite a long list of reasons why this agreement could have been impossible, he added.
There is not tradition of technology transfer, particularly in biotechnology, from Southern to Northern countries, generally speaking, and particularly in the case of Cuba and the United States, Lage affirmed. It is no secret that there is a 40-plus year void of a total absence of economic cooperation, a situation for which we have never blamed the U.S. people, far less the scientists of that country,” he said.
First Cuban-U.S. cooperation agreement for production of anti-cancer vaccines
• President Fidel Castro attends the document’s signing
BY REYNOLD RASSĂŤ -Granma daily staff writer-
ON July 15, and for the first time in 40 years, a cooperation agreement was signed by Cuban and U.S. companies for the transfer of biotechnological technology directed at developing vaccines against cancer. The agreement was signed between the CancerVax Corporation and the Center for Molecular Immunology at the International Conference Center in Havana.
------snip-------
For technical reasons, a complex negotiations process is already underway involving three different cancer vaccines, all under the protection of six patents from the Center for Molecular Immunology and the Genetic Engineering and Biotechnology Center, with different manufacturing processes, Lage noted.
“This negotiation has additional complications, and anyone could recite a long list of reasons why this agreement could have been impossible, he added.
There is not tradition of technology transfer, particularly in biotechnology, from Southern to Northern countries, generally speaking, and particularly in the case of Cuba and the United States, Lage affirmed. It is no secret that there is a 40-plus year void of a total absence of economic cooperation, a situation for which we have never blamed the U.S. people, far less the scientists of that country,” he said.